PDE4B Modulates Phosphorylation of p65 (Ser468) via cAMP/PKA in Acute Lung Injury

Rana Dhar1,2, Yajun Li3, Zhengqiang Hu1

  • 1Department of Pharmacology, Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University, Hangzhou, 310058, Zhejiang, China.

Lung
|February 16, 2025
PubMed
Abstract

Insights

Phosphodiesterase 4B (PDE4B) inhibition reduces lipopolysaccharide (LPS)-induced acute lung inflammation (ALI). PDE4B promotes inflammation by activating the cAMP/PKA pathway, leading to p65 phosphorylation.

Area of Science:

  • Immunology
  • Molecular Biology
  • Biochemistry

Background:

  • Phosphodiesterase 4B (PDE4B) is implicated in lipopolysaccharide (LPS)-induced acute lung injury (ALI).
  • The precise mechanisms underlying PDE4B's role in ALI remain incompletely understood.
  • This study investigates the relationship between PDE4B and p65 phosphorylation in LPS-induced injury.

Purpose of the Study:

  • To elucidate the role of PDE4B in LPS-induced acute lung inflammation.
  • To investigate the molecular mechanisms involving PDE4B, cAMP/PKA signaling, and p65 phosphorylation.
  • To determine PDE4B's function as a regulator in inflammatory responses.

Main Methods:

  • In vivo studies using wild-type and PDE4B-deficient mice stimulated with LPS.
  • In vitro experiments using MH-S cells with siRNA-mediated PDE4B knockdown and overexpression.
  • Analysis of inflammatory markers, cytokine levels (ELISA), protein signaling pathways (Western blotting), and luciferase assays.

Main Results:

  • PDE4B deficiency blunted LPS-induced inflammation, reducing immune cell infiltration and pro-inflammatory cytokines in mice.
  • PDE4B deficiency improved PKA expression and downregulated IKKα/β-NF-κB p65 signaling.
  • In vitro, PDE4B knockdown decreased p65 phosphorylation (Ser468) and inflammation markers, while overexpression increased them.
  • PDE4B acts as a positive regulator of p65 in inflammation via the cAMP/PKA axis.

Conclusions:

  • PDE4B plays a critical role in orchestrating LPS-induced acute lung inflammation.
  • The cAMP/PKA axis mediates PDE4B's effect through the phosphorylation of p65.
  • Targeting PDE4B may offer a therapeutic strategy for acute lung inflammation.

Related Concept Videos

cAMP-dependent Protein Kinase Pathways01:25

cAMP-dependent Protein Kinase Pathways

Cyclic Adenosine Monophosphate (cAMP) is an essential second messenger that activates protein kinase A (PKA) and regulates various biological processes. A single epinephrine molecule binds to GPCR and activates several heterotrimeric G proteins, each stimulating multiple adenylyl cyclase, amplifying the signal, and synthesizing large numbers of cAMP molecules. Small changes in cAMP concentration affect PKA activity. The binding of four cAMP molecules induces a conformational change in PKA,...
6.1K
GPCRs Regulate Adenylyl Cylase Activity01:09

GPCRs Regulate Adenylyl Cylase Activity

Some GPCRs transmit signals through adenylyl cyclase (AC), a transmembrane enzyme. AC helps synthesize second messenger cyclic adenosine monophosphate (cAMP). AC catalyzes cyclization reaction and converts ATP to cAMP by releasing a pyrophosphate. The pyrophosphate is further hydrolyzed to phosphate by the enzyme pyrophosphatase, which drives cAMP synthesis to completion. However, cAMP is rapidly degraded to 5′ AMP by the enzymes phosphodiesterase (PDE), preventing overstimulation of...
5.1K
IP3/DAG Signaling Pathway01:11

IP3/DAG Signaling Pathway

Membrane lipids such as phosphatidylinositol (PI) are precursors for several membrane-bound and soluble second messengers. Specific kinases phosphorylate PI and produce phosphorylated inositol phospholipids. One such inositol phospholipids are the  phosphatidylinositol-4,5 bisphosphate [PI(4,5)P2], present in the inner half of the lipid bilayer. Upon ligand binding, GPCR stimulates Gq proteins to turn on phospholipase Cꞵ. Activated phospholipase Cꞵ cleaves PI(4,5)P2 and...
11.8K
Amplifying Signals via Enzymatic Cascade01:22

Amplifying Signals via Enzymatic Cascade

When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze...
8.2K
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
8.6K
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
5.1K